Tirzepatide works well for people managing type 2 diabetes and wanting to lose weight
The transitional period before menopause is called menopause, which can last for a few years or a decade, usually in ones 40s
Elevated levels of IL-17 have been observed in ALD, correlating with the severity of hepatic inflammation and liver damage.66 IL-17 is heavily implicated in the recruitment of neutrophils to the liver, where it promotes alcohol-induced HCC by synergising with other inflammatory mediators.99 IL-17 amplifies the production of pro-inflammatory cytokines, including TNF- and IL-6, further driving the progression of liver injury.66 100 In patients with ALD, particularly those with AH and cirrhosis, IL-17-secreting cells, such as T lymphocytes and neutrophils, are abundant and significantly contribute to the inflammatory response.66 Studies have shown that HSCs expressing the IL-17 receptor can recruit neutrophils on IL-17 stimulation,66 promoting liver inflammation through the secretion of inflammatory mediators such as IL-8 and growth-related oncogene alpha.66 Blocking IL-17 has demonstrated protective effects in mouse models of alcohol-induced liver injury,67 including a reduction in voluntary alcohol consumption in alcohol-dependent mice,67 suggesting that targeting IL-17 could be a promising therapeutic strategy to attenuate liver inflammation and injury in ALD
The FDA initiated the review in mid-2023 after reports surfaced of suicidal ideation among some individuals using GLP-1 medications for weight loss
